MedPath

Treatment of Toothache with Unani medicine Raughan -e-Qaranful

Phase 3
Conditions
Health Condition 1: K00-K14- Diseases of oral cavity and salivary glands
Registration Number
CTRI/2019/08/020516
Lead Sponsor
Central Council for Research in Unani Medicine CCRUM
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

The following criteria will be strictly followed for inclusion of cases in this observational study.

1.Patients of either sex in the age group 18-65 years.

2.Patients having Waja al-Asnan (Toothache) with or without any of the following symptoms:

i.Waram al-Lisa (Gingival swelling)

ii.Humra al-Lisa (Gingival erythema)

iii.HassÄ?siyat HarÄ?riyya (Thermal sensitivity) â?? Pain triggered by Cold or Heat

iv.Headache

3.Patients with Waja al-Asnan (Toothache) ranging from 1-5 on Numeric Analogue Scale (NAS)

Exclusion Criteria

1. Patients with Waja al-Asnan (Toothache) ranging from 6-10 on Numeric Analogue Scale (NAS)

2. Known case of Neurological disorders

3. Known case of Oro-facial abscess and Cellulitis

4. Presence of concomitant Oral pain due to Oral ulcers

5. Known cases of Upper Respiratory tract Infection (URTI)

6. Known cases of severe Renal/ Hepatic/ DM

7. Pregnant and lactating women

8. History of Hypersensitivity/non-responsive to the study drug or any of its ingredients

9. History of addiction (alcohol, drugs)

10. Patients currently on antibiotic therapy

11. Pericoronitis (Pain due to eruption of third molar)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement in sign and symptoms of Waja al-Asnan (Toothache)Timepoint: 3days
Secondary Outcome Measures
NameTimeMethod
Haematological and biochemical assessment for safety assessmentTimepoint: Investigations will be done at baseline and end of treatment
© Copyright 2025. All Rights Reserved by MedPath